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INTRODUCTION: 
Spring Catarrh is also known as vernal conjunctivitis1. It 
is a type of bilateral seasonal allergic conjunctivitis. It is 
common in warm temperate climates during spring and 
summer season. Incidence is most common in young 
adults and children2. 
Spring catarrh is characterised by symptoms like itching, 
watering, foreign body sensation and Cobblestone like 
hypertrophied papillae on palpebral conjunctiva and 
limbal nodules with intense ropy and soapy discharge3. 
Recommended therapies include tropical steroids like 
prednisolone, FML and mast cell stabilisers and H1 
receptors antagonist like azelastine, sodium chromo 
glycate4, 5. 
All studies in literature show that patient will be relieved 
of symptoms but signs will persist though in reduced 
intensity. So efficacy of drug is to be gauged by grading 
the symptoms, which is subjective and varies from 
patient to patient6. 
 
 
           
Fig 1: Limbal Nodules           Fig 2: Cobble stone papillae 
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ABSTRACT:  
Aim: The study aims to test the efficiency of FML and Azelastine in the treatment of  vernal kerato conjunctivitis  by objective 
method of doing HPE of conjunctival scrapping before and 4 weeks after treatment with these two drugs.  
Material and method: A double blind randomised study conducted at a tertiary eye care centre in Hyderabad with a study 
period from July 2004 and July 2005. 100 patients of vernal kerato conjunctivitis were randomly divided in 2 groups of 50 
each. Group 1 was given FML eye drops 4 times daily for 4 weeks. Group 2 was given azelastine eye drops 4 times daily for 4 
weeks. All patients with VKC were included in the study. Patients with other eye disorders, corneal involvement, glaucoma 
and patients who received treatment within 1 month were excluded. HPE of conjunctival scrapping’s was done in both groups.  
Result: At the end of four weeks HPE was repeated 50 patients in group 1 showed absence of eosinophils and mast cells, 
whereas in group 2 only 15 cases showed absence of eosinophils and mast cells.  
Observation: Statistic chi square test show P value of 0 in group 1 and 0.3 in group 2 which is significant and proves that FML 
is superior to azelastine in the treatment of VKC. 
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Aims and Objectives: 
Aims and Objectives of current study is to know the 
efficacy of FML and azelastine in spring catarrh by 
objective method of doing H.P.E of conjunctival 
scrapping before and after treatment with the drug. 
MATERIALS AND METHODS:  
This is a randomised double blind study conducted on 
100 patients of spring catarrh attended by outpatient 
department of Sarojini Devi eye hospital which is a 
tertiary eye care centre in Hyderabad. The study was 
conducted from July 2004 to July 2005. All patients were 
clinically diagnosed as spring catarrh by an experienced 
ophthalmologist after doing slit lamp exam. Patients 
were in the age group of 10 – 30 years, both males and 
females were selected in study. 
Inclusion criteria: 
All patients with spring catarrh who didn’t receive any 
medication were included. 
Exclusion criteria: 
1. Patients of spring catarrh who received treatment 
within one month were excluded. 
2. Patient with corneal involvement were excluded7. 
3. Patients with glaucoma were excluded7. 
4. Patients with any other eye disease were also 
excluded. 
5. Patients who lost follow up were excluded from 
study. 
Patients were randomly divided into two groups of fifty 
each both groups were subjected to conjunctival scraping 
after anaesthetizing conjunctiva with 4% Xylocaine 
drops. 
Method of staining: 
 Conjunctival scraping were spread on glass slide and 
allowed to dry8.  
 Slide was flooded with Lieshmann stain. After two 
minutes double the volume of distilled water was 
poured on the slide and allowed to stay for 5 – 7 
minutes. 
 Then slide is washed with buffered water till it 
appears pink. 
 Slide is allowed to dry and studied under microscope 
in high power field. 
 High power field showed 25 – 30 epithelial cells 
from conjunctiva. 3- 4 eosinophils and 1 – 2 mast 
cells9. 
 After doing conjunctival scraping Group 1 receives 
fluorometholone 0.25 % 1 drop 4 times daily for 
four weeks. 
 Group 2 receives azelastine 0.05% 1 drop 4 times a 
day for 4 weeks. 
 Both patient and pathologist were unaware of the 
drug they were receiving. 
 At the end of four weeks again conjunctival scraping 
were taken for H.P.E.
 
 
                   
  
 Fig 3: Arrow showing eosinophil with bilobbed Nucleus          Fig 4: Arrow showing mast cell granules in Cytoplasm. 
                    
RESULT: 
Group 1 who received FML showed absence of 
eosinophils and mast cells at the end of four weeks in all 
50 cases. 
Group 2 who received azelastine showed presence of 
eosinophils and mast cells in 35 cases (i.e. more than 
50% of the cases). 
DISCUSSION: 
After 4 weeks of treatment with FML and azelastine the 
following observations were made. Group 1 which 
received FML was relieved of symptoms like itching, 
foreign body sensation and watering. There was relief 
from signs like reduction in size of limbal nodules and 
papillae. Group 2 which received azelastine showed less 
relief from symptoms and signs. 
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Fig 5: Before treatment showing eosinophil and mast 
cells 
 
Fig 6: Four weeks after treatment with FML Absent 
eosinophil and mast cells. 
 
Fig 7: Four weeks after treatment with azelastine Still 
showing eosinophils. 
CONCLUSION: 
This study shows that FML is Superior to azelastine 
for managing symptoms and signs of spring catarrh. 
FML also scores over azelastine objectively by 
showing absence of eosinophils and mast cells in 
H.P.E. H.P.E can be used as objective method to test 
the efficacy of drug while treating spring catarrh. 
Statistically it shows group 1 has P value of 0 and 
group 2 has P value of 0.3. 
 
Group 1:                                                                       Group2: 
Males 45  
Females 5 
                                                                    
                                               
               Group 1:                                                                       Group 2: 
Number of 
cases 
Number showing absence 
of eosinophils and mast 
cells 
  50 50 
 
It is significant that drug used in group 1 is superior to drug used in group 2. 
Note: Financial Interest Nil. 
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cases 
Number showing 
absence of eosinophils 
and mast cells 
50 15 
